Literature DB >> 18390994

Predicting relapse in Crohn's disease: a biopsychosocial model.

A Bitton1, P L Dobkin, M D Edwardes, M J Sewitch, J B Meddings, S Rawal, A Cohen, S Vermeire, L Dufresne, D Franchimont, G E Wild.   

Abstract

BACKGROUND: Crohn's disease (CD) is a chronic relapsing inflammatory bowel disorder. Both biological and psychosocial factors may modulate the illness experience. AIM: The aim of this study was to identify clinical, biological and psychosocial parameters as predictors of clinical relapse in quiescent CD.
METHODS: Patients in medically induced remission were followed prospectively for 1 year, or less if they relapsed. Disease characteristics were determined at baseline. Serum cytokines, anti-Saccharomyces cerevisiae antibodies, C-reactive protein (CRP), erythrocyte sedimentation rate and intestinal permeability were measured every 3 months. Psychological distress, perceived stress, minor life stressors and coping strategies were measured monthly. A time-dependent multivariate Cox regression model determined predictors of time to relapse.
RESULTS: 101 patients (60 females, 41 males) were recruited. Fourteen withdrew and 37 relapsed. CRP (HR = 1.5 per 10 mg/l, 95% CI 1.1 to 1.9, p = 0.007), fistulising disease (HR = 3.2, 95% CI, 1.1 to 9.4, p = 0.04), colitis (HR = 3.5 95% CI 1.2 to 9.9, p = 0.02) and the interaction between perceived stress and avoidance coping (HR = 7.0 per 5 unit increase for both scales, 95% CI 2.3 to 21.8, p = 0.003) were predictors of earlier relapse.
CONCLUSIONS: In quiescent CD, a higher CRP, fistulising disease behaviour and disease confined to the colon were independent predictors of relapse. Moreover, patients under conditions of low stress and who scored low on avoidance coping (ie, did not engage in social diversion or distraction) were least likely to relapse. This study supports a biopsychosocial model of CD exacerbation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18390994     DOI: 10.1136/gut.2007.134817

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  80 in total

1.  Acute stress elicited by bungee jumping suppresses human innate immunity.

Authors:  David J van Westerloo; Goda Choi; Ester C Löwenberg; Jasper Truijen; Alex F de Vos; Erik Endert; Joost C M Meijers; Lu Zhou; Manuel P F L Pereira; Karla C S Queiroz; Sander H Diks; Marcel Levi; Maikel P Peppelenbosch; Tom van der Poll
Journal:  Mol Med       Date:  2010-12-10       Impact factor: 6.354

Review 2.  The epidemiology and risk factors of inflammatory bowel disease.

Authors:  Yulan Ye; Zhi Pang; Weichang Chen; Songwen Ju; Chunli Zhou
Journal:  Int J Clin Exp Med       Date:  2015-12-15

Review 3.  Inflammatory bowel disease (IBD) position statement of the Italian Society of Colorectal Surgery (SICCR): general principles of IBD management.

Authors:  G Pellino; D S Keller; G M Sampietro; V Annese; M Carvello; V Celentano; C Coco; F Colombo; N Cracco; F Di Candido; M Franceschi; S Laureti; G Mattioli; L Pio; G Sciaudone; G Sica; V Villanacci; R Zinicola; S Leone; S Danese; A Spinelli; G Delaini; F Selvaggi
Journal:  Tech Coloproctol       Date:  2020-01-25       Impact factor: 3.781

Review 4.  Mechanisms and functional implications of intestinal barrier defects.

Authors:  Le Shen; Liping Su; Jerrold R Turner
Journal:  Dig Dis       Date:  2009-11-04       Impact factor: 2.404

Review 5.  Environmental factors in the relapse and recurrence of inflammatory bowel disease: a review of the literature.

Authors:  Thomas D Martin; Simon S M Chan; Andrew R Hart
Journal:  Dig Dis Sci       Date:  2014-11-19       Impact factor: 3.199

6.  Predictors of health-related quality of life and adherence in Crohn's disease and ulcerative colitis: implications for clinical management.

Authors:  Anilga Tabibian; James H Tabibian; Linda J Beckman; Laura L Raffals; Konstantinos A Papadakis; Sunanda V Kane
Journal:  Dig Dis Sci       Date:  2015-01-06       Impact factor: 3.199

Review 7.  Epidemiology and risk factors for IBD.

Authors:  Ashwin N Ananthakrishnan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-03       Impact factor: 46.802

Review 8.  Biomarkers in inflammatory bowel disease: current practices and recent advances.

Authors:  Heba N Iskandar; Matthew A Ciorba
Journal:  Transl Res       Date:  2012-02-01       Impact factor: 7.012

Review 9.  Environmental triggers for inflammatory bowel disease.

Authors:  Ashwin N Ananthakrishnan
Journal:  Curr Gastroenterol Rep       Date:  2013-01

Review 10.  Diagnostic advances in inflammatory bowel disease (imaging and laboratory).

Authors:  Maria E Moscandrew; Edward V Loftus
Journal:  Curr Gastroenterol Rep       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.